Computed tomography scan made for clinical reasons
OtherPatients were included if a computed tomography scan of the abdomen or thorax was made early during intensive care admission (1 day before up to 4 days after admission)
NCT Number: NCT02817646
The purpose of this study is to determine whether protein intake during the first days of intensive care admission, in relation to body composition at intensive care admission as assessed on computed tomography scans made during routine care, is are related to clinical outcome in critically ill patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Optimal protein and energy intake have been shown to be relevant for reducing mortality in prospective observational studies in mechanically ventilated patients admitted to the intensive care unit. However, nutritional status (protein mass, muscle mass) of patients at admission and possible consequences for clinical outcome are largely unknown. Computerized tomography scans can be used to assess muscle mass as a proxy for body protein mass.
The investigators are especially interested in the effect of protein intake on clinical outcome in intensive care patients with different body protein mass at admission. This is relevant for appropriate formulation of clinical (protein) nutrition in this patient group. Therefore, the relationship between protein intake and patient outcome is evaluated in intensive care patients with low muscle and normal muscle area, using muscle area from computed tomography scans as a proxy of body protein mass.
Additionally, data from computed tomography scans regarding muscle quality and muscle- and fat quantity are used to evaluate the prognostic value of body composition at intensive care admission. Finally, abdominal computed tomography scans are compared with thoracic computed tomography scans.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients were included if a computed tomography scan of the abdomen or thorax was made early during intensive care admission (1 day before up to 4 days after admission)
Patients received enteral and/or parenteral nutrition as per usual hospital protocol
Time frame: 6-months after intensive care admission
Time frame: 28-days after intensive care admission
Time frame: 60-days after intensive care admission
Time frame: 90-days after intensive care admission
Time frame: From admission to the intensive care unit untill discharge from the intensive care unit, an average of two weeks
Time frame: From admission to the intensive care unit untill discharge from the hospital, an average of one month
Time frame: After discharge from the hospital, on average after one month
Time frame: The total duration of admission to the hospital, an average of one month
Time frame: The total duration of admission to the intensive care unit, an average of two weeks
Time frame: The total duration of mechanical ventilation during intensive care unit stay, an average of 10 days
Amsterdam UMC, location VUmc
Other
A Retrospective Investigator Initiated Trial Evaluating Protein Intake and CT Assessments of Muscle Mass of Critically Ill Patients in Relation to Outcome Parameters: the PROMUS-study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02034942
Atrophy, Critical Illness
Kolding, Denmark
View Trial DetailsNCT05156320
Anti-myostatin, Atrophy
Birmingham, Alabama, United States
View Trial DetailsNCT06233825
Anterior Cruciate Ligament Reconstruction, Atrophy
Kingston, Ontario, Canada
View Trial DetailsNCT02912130
Atrophy, Behavior
Liverpool, Merseyside, United Kingdom
View Trial Details